Active Tuberculosis in Patients with Psoriasis Receiving Biologic Therapy: A Systematic Review

Authors:

Abstract
Biologic therapies pose a risk for opportunistic infections, especially for reactivating latent tuberculosis infection (LTBI).

This publication has 69 references indexed in Scilit: